Maja Miloslavsky

2.8k total citations
10 papers, 399 citations indexed

About

Maja Miloslavsky is a scholar working on Urology, Hematology and Psychiatry and Mental health. According to data from OpenAlex, Maja Miloslavsky has authored 10 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Urology, 4 papers in Hematology and 4 papers in Psychiatry and Mental health. Recurrent topics in Maja Miloslavsky's work include Sexual function and dysfunction studies (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (4 papers). Maja Miloslavsky is often cited by papers focused on Sexual function and dysfunction studies (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (4 papers). Maja Miloslavsky collaborates with scholars based in United States. Maja Miloslavsky's co-authors include Christopher P. Steidle, Stanley E. Althof, Sherron Kell, Jon L. Pryor, Ridwan Shabsigh, Wayne J.G. Hellstrom, Raymond C. Rosen, Thomas Roth, Richard Bogan and Jonathan Schwartz and has published in prestigious journals such as The Lancet, Blood and The Journal of Urology.

In The Last Decade

Maja Miloslavsky

10 papers receiving 374 citations

Peers

Maja Miloslavsky
Huixing Yuan United States
Nandan Koppiker United Kingdom
Amr Abdel Raheem United Kingdom
Martin Kathrins United States
Kweon Sik Min South Korea
Regula E. Bürki United States
Huixing Yuan United States
Maja Miloslavsky
Citations per year, relative to Maja Miloslavsky Maja Miloslavsky (= 1×) peers Huixing Yuan

Countries citing papers authored by Maja Miloslavsky

Since Specialization
Citations

This map shows the geographic impact of Maja Miloslavsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Miloslavsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Miloslavsky more than expected).

Fields of papers citing papers by Maja Miloslavsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Miloslavsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Miloslavsky. The network helps show where Maja Miloslavsky may publish in the future.

Co-authorship network of co-authors of Maja Miloslavsky

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Miloslavsky. A scholar is included among the top collaborators of Maja Miloslavsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Miloslavsky. Maja Miloslavsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2017). Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. Biology of Blood and Marrow Transplantation. 23(6). 997–1004. 44 indexed citations
2.
Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2017). Earlier defibrotide initiation post‐diagnosis of veno‐occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. British Journal of Haematology. 178(1). 112–118. 61 indexed citations
3.
Richardson, Paul G., Brandon M. Triplett, Nancy A. Kernan, et al.. (2016). Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival. Biology of Blood and Marrow Transplantation. 22(3). S82–S83. 2 indexed citations
4.
Bogan, Richard, Thomas Roth, Jonathan Schwartz, & Maja Miloslavsky. (2015). Time to Response with Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy. Journal of Clinical Sleep Medicine. 11(4). 427–432. 37 indexed citations
5.
Richardson, Paul G., Angela R. Smith, Brandon M. Triplett, et al.. (2015). Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival. Blood. 126(23). 4311–4311. 1 indexed citations
6.
Pryor, Jon L., Stanley E. Althof, Christopher P. Steidle, et al.. (2006). Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. The Lancet. 368(9539). 929–937. 227 indexed citations
7.
Hellstrom, Wayne J.G., Ira D. Sharlip, & Maja Miloslavsky. (2006). 917: Efficacy of Dapoxetine in Men with Self-Rated Very Poor Control Over Ejaculation. The Journal of Urology. 175(4S). 297–297. 2 indexed citations
8.
Shabsigh, Ridwan, et al.. (2006). LONG-TERM SAFETY AND TOLERABILITY OF DAPOXETINE FOR THE TREATMENT OF MEN WITH PREMATURE EJACULATION. European Urology Supplements. 5(2). 66–66. 4 indexed citations
9.
Shabsigh, Ridwan, Gregory A. Broderick, Maja Miloslavsky, & Scott Bull. (2006). 918: Dapoxetine has Long-Term Efficacy in the Treatment of Premature Ejaculation. The Journal of Urology. 175(4S). 297–298. 4 indexed citations
10.
Pryor, Jon L., Stanley E. Althof, Christopher P. Steidle, Maja Miloslavsky, & Sherron Kell. (2005). 740: Efficacy and Tolerability of Dapoxetine in the Treatment of Premature Ejaculation. The Journal of Urology. 173(4S). 201–202. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026